| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ahmet Kokurca. Comparison of Clinical Characteristics Between the Patients with Schizophrenia on Clozapine Treatment with Those Taking Combination of Long-Acting Injectable and Oral Antipsychotics. Noro psikiyatri arsivi. vol 56. issue 3. 2020-10-01. PMID:31523150. |
comparison of clinical characteristics between the patients with schizophrenia on clozapine treatment with those taking combination of long-acting injectable and oral antipsychotics. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ahmet Kokurca. Comparison of Clinical Characteristics Between the Patients with Schizophrenia on Clozapine Treatment with Those Taking Combination of Long-Acting Injectable and Oral Antipsychotics. Noro psikiyatri arsivi. vol 56. issue 3. 2020-10-01. PMID:31523150. |
the primary aim of this study was to compare clinical characteristics between the patients with schizophrenia on clozapine treatment with those under combination of long-acting injectable and oral antipsychotics (combined treatment), and the secondary aim was to evaluate the impact of obsessive-compulsive disorder (ocd) comorbidity on the clinical variables. |
2020-10-01 |
2023-08-13 |
Not clear |
| Bahareh Sadat Yousefsani, Seyed Ahmad Mohajeri, Mohammad Moshiri, Amir Hossein Jafarian, Hossein Hosseinzade. Effect of Intravenous Lipid Emulsion on Clozapine Acute Toxicity in Rats. Journal of pharmacopuncture. vol 22. issue 3. 2020-10-01. PMID:31673444. |
clozapine, highly lipophilic dibenzodiazepine neuroleptics, is an important medication in the schizophrenia therapy regimen. |
2020-10-01 |
2023-08-13 |
rat |
| Thomas Van der Poorten, Marc De Her. The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: A systematic review. Clinical case reports. vol 7. issue 11. 2020-10-01. PMID:31788260. |
clozapine is considered the golden standard in the treatment of therapy-resistant schizophrenia; however, it associated with bothersome side effects such as sialorrhea. |
2020-10-01 |
2023-08-13 |
Not clear |
| James L Roeri. Clozapine augmentation strategies. The mental health clinician. vol 9. issue 6. 2020-10-01. PMID:31857930. |
clozapine is established as the gold standard for antipsychotic treatment of patients suffering from treatment-resistant schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Frank G A Jansman, Heleen A Crommelin, Freek J A H van Hout, Jan Meulenbel. Rhabdomyolysis in Clozapine Overdose. Drug safety - case reports. vol 2. issue 1. 2020-09-30. PMID:27747721. |
clozapine is used for decennia for the treatment of schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Nilamadhab Kar, Socorro Barreto, Rahul Chandavarka. Clozapine Monitoring in Clinical Practice: Beyond the Mandatory Requirement. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 14. issue 4. 2020-09-30. PMID:27776383. |
clozapine is effective in treatment resistant schizophrenia; however, it is underutilised probably because of its side effects. |
2020-09-30 |
2023-08-13 |
Not clear |
| Aslıhan Polat, Uğur Çakir, Nermin Gündü. Leukocytosis after Clozapine Treatment in a Patient with Chronic Schizophrenia. Noro psikiyatri arsivi. vol 53. issue 1. 2020-09-30. PMID:28360774. |
leukocytosis after clozapine treatment in a patient with chronic schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Alejandro Porras-Segovia, Amir Krivoy, Mark Horowitz, George Thomas, Mark Bolstridge, Dragos Ion, Sukhwinder S Shergil. Rapid-onset clozapine-induced loss of glycaemic control: case report. BJPsych open. vol 3. issue 3. 2020-09-30. PMID:28507773. |
clozapine has proved to be an effective antipsychotic for the treatment of refractory schizophrenia - characterised by the persistence of symptoms despite optimal treatment trials with at least two different antipsychotics at adequate dose and duration - but its use is hampered by adverse effects. |
2020-09-30 |
2023-08-13 |
Not clear |
| Alejandro Porras-Segovia, Amir Krivoy, Mark Horowitz, George Thomas, Mark Bolstridge, Dragos Ion, Sukhwinder S Shergil. Rapid-onset clozapine-induced loss of glycaemic control: case report. BJPsych open. vol 3. issue 3. 2020-09-30. PMID:28507773. |
we present the case of an individual with refractory schizophrenia and metformin-controlled diabetes who developed rapid-onset insulin-dependent hyperglycaemia immediately after starting clozapine. |
2020-09-30 |
2023-08-13 |
Not clear |
| George E Banis, Thomas Winkler, Patricia Barton, Sheryl E Chocron, Eunkyoung Kim, Deanna L Kelly, Gregory F Payne, Hadar Ben-Yoav, Reza Ghodss. The Binding Effect of Proteins on Medications and Its Impact on Electrochemical Sensing: Antipsychotic Clozapine as a Case Study. Pharmaceuticals (Basel, Switzerland). vol 10. issue 3. 2020-09-30. PMID:28763030. |
clozapine (clz), a dibenzodiazepine, is demonstrated as the optimal antipsychotic for patients suffering from treatment-resistant schizophrenia. |
2020-09-30 |
2023-08-13 |
human |
| Vivekananda Rachamallu, Ayman Haq, Michael M Song, Manish Aliget. Clozapine-Induced Microseizures, Orofacial Dyskinesia, and Speech Dysfluency in an Adolescent with Treatment Resistant Early Onset Schizophrenia on Concurrent Lithium Therapy. Case reports in psychiatry. vol 2017. 2020-09-30. PMID:28835863. |
clozapine is an atypical antipsychotic used in the treatment of refractory schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Vivekananda Rachamallu, Ayman Haq, Michael M Song, Manish Aliget. Clozapine-Induced Microseizures, Orofacial Dyskinesia, and Speech Dysfluency in an Adolescent with Treatment Resistant Early Onset Schizophrenia on Concurrent Lithium Therapy. Case reports in psychiatry. vol 2017. 2020-09-30. PMID:28835863. |
here, we report on the development of clozapine-induced microseizures, orofacial dyskinesia, and stuttering in a 17-year-old adolescent male with treatment of refractory early onset schizophrenia on clozapine and concurrent lithium therapy. |
2020-09-30 |
2023-08-13 |
Not clear |
| Vivekananda Rachamallu, Ayman Haq, Michael M Song, Manish Aliget. Clozapine-Induced Microseizures, Orofacial Dyskinesia, and Speech Dysfluency in an Adolescent with Treatment Resistant Early Onset Schizophrenia on Concurrent Lithium Therapy. Case reports in psychiatry. vol 2017. 2020-09-30. PMID:28835863. |
the patient's symptoms of schizophrenia responded well to the clozapine regimen. |
2020-09-30 |
2023-08-13 |
Not clear |
| Basel A Abdel-Wahab, Metwally E Metwall. Clozapine-induced cardiotoxicity in rats: Involvement of tumour necrosis factor alpha, NF-κβ and caspase-3. Toxicology reports. vol 1. 2020-09-30. PMID:28962331. |
clozapine, an ideal antipsychotic drug for the treatment of resistant schizophrenia, is considered the most underutilised treatment for schizophrenia. |
2020-09-30 |
2023-08-13 |
rat |
| Thomas E Winkler, Florence O Stevenson, Eunkyoung Kim, Mijeong Kang, Gregory F Payne, Deanna L Kelly, Reza Ghodss. The Role of Microsystems Integration Towards Point-of-Care Clozapine Treatment Monitoring in Schizophrenia. IEEE sensors letters. vol 2. issue 1. 2020-09-30. PMID:29308452. |
the role of microsystems integration towards point-of-care clozapine treatment monitoring in schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Thomas E Winkler, Florence O Stevenson, Eunkyoung Kim, Mijeong Kang, Gregory F Payne, Deanna L Kelly, Reza Ghodss. The Role of Microsystems Integration Towards Point-of-Care Clozapine Treatment Monitoring in Schizophrenia. IEEE sensors letters. vol 2. issue 1. 2020-09-30. PMID:29308452. |
our study is specifically geared toward schizophrenia treatment, where concurrent blood monitoring of the antipsychotic clozapine and white blood cells could lead to improved treatment outcomes. |
2020-09-30 |
2023-08-13 |
Not clear |
| Andrew Shaker, Rowena Jone. Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service. Therapeutic advances in psychopharmacology. vol 8. issue 1. 2020-09-30. PMID:29344339. |
clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service. |
2020-09-30 |
2023-08-13 |
Not clear |
| Andrew Shaker, Rowena Jone. Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service. Therapeutic advances in psychopharmacology. vol 8. issue 1. 2020-09-30. PMID:29344339. |
research in patients with treatment-resistant schizophrenia has demonstrated that clozapine discontinuation is associated with poor outcomes. |
2020-09-30 |
2023-08-13 |
Not clear |
| Andrew Shaker, Rowena Jone. Clozapine discontinuation in early schizophrenia: a retrospective case note review of patients under an early intervention service. Therapeutic advances in psychopharmacology. vol 8. issue 1. 2020-09-30. PMID:29344339. |
there is, however, a paucity of research investigating the impact of clozapine discontinuation specifically in younger patients with more recent onset schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |